Hologic and Siemens Healthineers trade patent-infringement lawsuits

Imaging manufacturers Hologic and Siemens Healthineers both recently sued one another, alleging their competitor has infringed on key medical imaging patents. 

In the most recent case, Hologic filed suit in a Delaware U.S. District Court on Nov. 16, claiming Siemens’ Mammomat B.brilliant mammography systems utilize its own patented products. 

Hologic says the scanners incorporate patented focal-spot compensation technology, which is employed during a breast tomosynthesis exam. This same B.brilliant product concern has already been adjudicated overseas, the complaint notes, with the European Unified Patent Court ruling in June that Siemens Healthineers is guilty of copyright infringement. 

“Although the claims asserted in this action are United States patent claims and infringement must be determined independently under United States law, the [European Unified Patent Court] proceeding is relevant to the parties’ history and to Siemens’ knowledge of Hologic’s focal-spot-control technology,” the complaint charges. 

As reported in June, the European case centered around the Mammomat B.brilliant breast tomosynthesis system’s “Flying Focal Spot” technology. This enables the static focus spot to move in the opposite direction in the tube during an exposure, which in turn produces sharper, more detailed images. 

Hologic claims it is responsible for creating this technology. The company first filed a patent infringement lawsuit against Siemens Healthineers in 2024, alleging its competitor had profited from the alleged theft. Siemens defended its claim to the technology to no avail, as Europe’s patent court ruled in Hologic’s favor on June 10. 

Subscribe to Radiology Business News

Bloomberg Law first reported news of the U.S. lawsuit on Tuesday. It notes that Hologic is seeking monetary damages and a permanent injunction preventing Siemens from creating, selling or importing the accused product. 

Meanwhile, Siemens Healthineers filed its own patent lawsuit against Hologic in the same Delaware District Court on Nov. 13. In the complaint, Siemens claims that Hologic’s Envision Mammography Platform knocks off its own technology. 

Siemens said the patent in question pertains to an identified problem with conventional tomosynthesis image acquisition. A conventional scanner uses a “stop and shoot” procedure, in which the X-ray tube remains stationary while each projection image is acquired. However, repeatedly stopping, scanning and moving the tube increases total acquisition times. 

To address this, patent '894 outlines a method of acquiring projection images during continuous rotational movement of the X-ray tube while moving the electron-beam focal spot on the tube’s anode in the direction opposite the tube’s movement. The focal-spot movement then compensates for the distance traveled by the tube during each image acquisition, according to the complaint. 

“The patented technology thereby produces motion-blur-free images in a shorter total acquisition time,” it notes. 

"On information and belief, Hologic actively, knowingly, and intentionally induces infringement of the asserted claims of the ’894 Patent by actively encouraging others—including hospitals, imaging centers, radiologists, and technologists—to make, use, offer to sell, and/or sell the accused products in the United States in violation of [U.S. Patent laws]," attorneys add later. 

Siemens is also seeking an injunction to stop use of this technology, along with a jury trial to determine other damages. Both Siemens Healthineers and Hologic did not immediately respond to a Radiology Business request for comment late Tuesday. 

Radiology Business Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Subscribe to Radiology Business News

Subscribe to Radiology Business News